Ensemble Therapeutics Corporation

Ensemble Discovery Appoints Jean Jacques Bienaime to its Board of Directors

Ensemble Discovery Appoints Jean Jacques Bienaime to its Board of Directors

August 30, 2005

Cambridge, Mass., (August 30, 2005) -- Ensemble Discovery Corporation today announced the appointment of Jean-Jacques Bienaime to its Board of Directors. Mr. Bienaime is currently the Chief Executive Officer of BioMarin Pharmaceuticals Inc.

VisEn Medical, Inc.

VisEn Medical Announces the Launch of an Industry-First FMT Imaging System and Optical Probe Product Line

VisEn Medical Announces the Launch of an Industry-First FMT Imaging System and Optical Probe Product Line

September 2, 2005

Backed by 18 Abstracts at the 4th Annual Meeting of the Society For Molecular Imaging

New digs, direction for BG Medicine

New digs, direction for BG Medicine

September 13, 2005

Mass High Tech Online
09/12/2005 08:26 AM
By Dyke Hendrickson


BG Medicine Inc. moved recently into larger headquarters in Waltham -- a larger space to accommodate a big idea.

Epitome Biosystems

Epitome Biosystems to Develop Multiplex Assay Reagents for EMD Biosciences

Epitome Biosystems to Develop Multiplex Assay Reagents for EMD Biosciences

September 14, 2005

WALTHAM, Mass., Sept. 14 /PRNewswire/ -- Epitome Biosystems announced today that it has signed a licensing and development agreement with EMD Biosciences for products based on Epitome's proprietary EpiTag(TM) technology. Specifically, Epitome will develop reagents for the quantitative measurement of key intracellular signaling proteins. The companies will collaborate on development and the products will be marketed and sold for research applications on a world-wide basis by EMD Biosciences under its well-known Novagen(R) and Calbiochem(R) brands.

IntelliVid

Department Store Selects IntelliVid's Intelligent Video Analysis Solution for Loss Prevention

Department Store Selects IntelliVid's Intelligent Video Analysis Solution for Loss Prevention

September 26, 2005

CAMBRIDGE -- IntelliVid Corporation, the leader in intelligent video analysis software for retail loss prevention, today announced that a leading fashion-oriented department store has chosen its Video Investigator™ software to transform the retailer's existing closed-circuit television (CCTV) systems into a solution that enhances the shopping environment and pro-actively reduces inventory losses.

Pervasis Therapeutics, Inc.

Pervasis Therapeutics Closes $12 Million Series B Financing

Pervasis Therapeutics Closes $12 Million Series B Financing

September 30, 2005

Cell Therapy Company Developing Next-Generation Combination Treatments

Pervasis Therapeutics, Inc.

Pervasis Therapeutics Expands Team to Bring to Market Medical Therapies for Treating Cardiovascular Diseases

Pervasis Therapeutics Expands Team to Bring to Market Medical Therapies for Treating Cardiovascular Diseases

September 30, 2005

Cell Therapy Company Adds Industry Heavyweights to Leadership Team

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sep 30, 2005 - Pervasis Therapeutics, Inc., a biotechnology company founded to develop the next generation of medical therapies that integrate biomaterials with cells and drugs, today announced several recent additions to its quickly growing team, including a president, senior advisor and two independent directors.

Zalicus

CombinatoRx and Angiotech Sign Agreement to Apply CombinatoRx's Pipeline and Technology to the Field of Intervational Medicines

CombinatoRx and Angiotech Sign Agreement to Apply CombinatoRx's Pipeline and Technology to the Field of Intervational Medicines

October 3, 2005

CombinatoRx to receive $42 million on closing: $27 Million Upfront plus $15 Million Equity Investment To Discover and Develop Drug-Device Combinations and Local Interventional Medicines

e-Dialog, Inc.

e-Dialog Ranks Highest Overall Among Service-Oriented E-mail Marketing Providers in Independent Survey

e-Dialog Ranks Highest Overall Among Service-Oriented E-mail Marketing Providers in Independent Survey

October 18, 2005

Prominent Analyst Cites Company's Business Value, Account Servicing, Strategic and Creative Input, Campaign Management and Analysis Applications as Keys to Success

BG Medicine, Inc.

BG Medicine and FDA to Conduct Joint Biomarker Discovery Study to Improve Prediction of Human Liver Toxicity in Drug Development Process

BG Medicine and FDA to Conduct Joint Biomarker Discovery Study to Improve Prediction of Human Liver Toxicity in Drug Development Process

October 25, 2005

Study to Provide Solutions to Primary Obstacles in the Development of New Pharmaceuticals